Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
21.57
+0.01 (0.05%)
At close: Jan 30, 2026, 4:00 PM EST
21.55
-0.02 (-0.09%)
After-hours: Jan 30, 2026, 4:10 PM EST

Avadel Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-0.28-48.83-160.28-137.46-77.337.03
Depreciation & Amortization
3.682.681.771.490.821.69
Other Amortization
--2.86.051.256.52
Loss (Gain) From Sale of Assets
------45.76
Asset Writedown & Restructuring Costs
20-----
Stock-Based Compensation
18.5620.3915.817.018.873
Other Operating Activities
-0.82-0.8314.3928.07-14.61-6.89
Change in Accounts Receivable
-5.34-21.99-12.1--8.28
Change in Inventory
-8.01-9.22-9.53---1.35
Change in Accounts Payable
4.49-4.091.55-3.114.23-2.79
Change in Other Net Operating Assets
2.2714.9917.0927.64-0.54-18.47
Operating Cash Flow
34.54-46.91-128.51-70.3-77.31-48.73
Capital Expenditures
-0.19---0.72-0.03-0.1
Divestitures
----16.525.5
Sale (Purchase) of Intangibles
-15-----
Investment in Securities
25.7351.78-50.0980.4140.46-95.12
Investing Cash Flow
10.5451.78-50.0979.756.93-69.72
Long-Term Debt Repaid
---38.67-8.65--
Net Debt Issued (Repaid)
---38.67-8.65--
Issuance of Common Stock
5.0615.97148.36280.26179.68
Other Financing Activities
--25.64-4.8--
Financing Cash Flow
5.0615.97135.3414.540.26179.68
Foreign Exchange Rate Adjustments
1.09-0.640.46-0.66-0.90.72
Net Cash Flow
51.2320.2-42.8123.27-21.0161.95
Free Cash Flow
34.35-46.91-128.51-71.02-77.34-48.83
Free Cash Flow Margin
13.82%-27.74%-459.57%---218.64%
Free Cash Flow Per Share
0.35-0.49-1.60-1.18-1.32-0.89
Cash Interest Paid
10.297.185.259.666.476.47
Cash Income Tax Paid
----29.060.08-1.7
Levered Free Cash Flow
2.73-30.37-78.68-25.39-38.03-57.42
Unlevered Free Cash Flow
8.8-23.6-75.3-23.73-33.07-55.83
Change in Working Capital
-6.59-20.32-324.543.7-14.32
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q